Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC08 Decitabine
D03665 Decitabine (USAN/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antimetabolites
Decitabine
D03665 Decitabine (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
D03665 Decitabine
Drug classes [BR:br08332]
Antineoplastic
DG02018 Antimetabolite
D03665 Decitabine
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
DNMT
D03665 Decitabine (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03665
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03665
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03665